Today, 2026 it is estimated that there are over 40 million caregivers in the United States and it is estimated that the global burden of dementia is projected to more than double by 2050 [1]. Pharmacologic therapies offer modest symptomatic benefit but limited diseasemodifying effects [2] Click here to read more